Reckitt CEO stands by Mead Johnson deal, despite Pfizer option
Reckitt Benckiser has no regrets about its $17 billion (12.3 billion pounds) acquisition of Mead Johnson last year, its chief executive said, even though there are concerns it may now be too stretched to buy Pfizer’s coveted consumer health business. The Pfizer business, which is currently on the block, would fulfil Reckitt CEO Rakesh Kapoor’s long-stated plan to transform Reckitt from a British maker of household cleaning products into a global leader in consumer healthcare.
Source:: https://finance.yahoo.com/news/reckitt-ceo-stands-mead-johnson-101936652.html
